Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Shares Acquired by Private Advisor Group LLC

Private Advisor Group LLC lifted its stake in shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) by 14.3% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 20,738 shares of the company’s stock after purchasing an additional 2,587 shares during the period. Private Advisor Group LLC owned approximately 0.34% of Global X Genomics & Biotechnology ETF worth $165,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. Creative Financial Designs Inc. ADV purchased a new stake in shares of Global X Genomics & Biotechnology ETF in the 1st quarter valued at approximately $95,000. Oppenheimer Asset Management Inc. lifted its holdings in shares of Global X Genomics & Biotechnology ETF by 35.8% in the first quarter. Oppenheimer Asset Management Inc. now owns 82,923 shares of the company’s stock valued at $659,000 after purchasing an additional 21,847 shares in the last quarter. Comprehensive Money Management Services LLC lifted its holdings in shares of Global X Genomics & Biotechnology ETF by 10.9% in the first quarter. Comprehensive Money Management Services LLC now owns 20,355 shares of the company’s stock valued at $162,000 after purchasing an additional 2,000 shares in the last quarter. Oxinas Partners Wealth Management LLC boosted its position in shares of Global X Genomics & Biotechnology ETF by 35.9% in the first quarter. Oxinas Partners Wealth Management LLC now owns 14,461 shares of the company’s stock worth $115,000 after buying an additional 3,818 shares during the period. Finally, Insight Advisors LLC PA grew its holdings in shares of Global X Genomics & Biotechnology ETF by 38.2% during the first quarter. Insight Advisors LLC PA now owns 40,356 shares of the company’s stock valued at $321,000 after buying an additional 11,164 shares in the last quarter. 56.95% of the stock is owned by hedge funds and other institutional investors.

Global X Genomics & Biotechnology ETF Trading Down 0.7%

NASDAQ:GNOM opened at $8.61 on Friday. Global X Genomics & Biotechnology ETF has a 1-year low of $6.80 and a 1-year high of $11.68. The firm has a market capitalization of $43.22 million, a price-to-earnings ratio of -3.68 and a beta of 1.03. The business’s fifty day moving average price is $8.47 and its 200 day moving average price is $8.60.

Global X Genomics & Biotechnology ETF Announces Dividend

The firm also recently disclosed a dividend, which was paid on Monday, July 7th. Stockholders of record on Friday, June 27th were given a $0.0083 dividend. The ex-dividend date of this dividend was Friday, June 27th.

Global X Genomics & Biotechnology ETF Company Profile

Complete Genomics, Inc is a life sciences company that has developed and commercialized a deoxyribonucleic acid (DNA) sequencing platform. Its complete genomics analysis platform (CGA) Platform, combines its human genome sequencing technology with its advanced informatics and data management software and its end-to-end, outsourced service model to provide its customers with data that is ready to be used for genome-based research.